
Jan 15 (Reuters) - Boston Scientific Corp BSX.N:
BOSTON SCIENTIFIC ANNOUNCES AGREEMENT TO ACQUIRE PENUMBRA, INC.
BOSTON SCIENTIFIC CORP - DEAL VALUES PENUMBRA AT $14.5 BILLION
BOSTON SCIENTIFIC CORP - PENUMBRA SHAREHOLDERS CAN ELECT CASH OR STOCK
PENUMBRA INC: PROPOSED DEAL FOR $374 PER SHARE
PENUMBRA INC: EXPECTS TO DELIVER Q4 REPORTED REVENUE GROWTH IN RANGE OF ABOUT 21.4% - 22.0%
BOSTON SCIENTIFIC CORP: EXPECTS TO FINANCE ABOUT $11 BILLION CASH PORTION OF TRANSACTION CONSIDERATION WITH A COMBINATION OF CASH ON HAND AND NEW DEBT
BOSTON SCIENTIFIC - DEAL EXPECTED TO BE $0.06-$0.08 DILUTIVE TO ADJUSTED EPS IN FIRST FULL YEAR
BOSTON SCIENTIFIC CORP: EXPECTS FY 2025 REPORTED REVENUE ABOUT $1.4 BILLION
BOSTON SCIENTIFIC CORP: DEAL TO BE NEUTRAL TO SLIGHTLY ACCRETIVE TO ADJUSTED EPS IN SECOND YEAR AND MORE ACCRETIVE THEREAFTER